TIA
LLY icon

Traphagen Investment Advisors’s Eli Lilly LLY Stock Holding History

Traphagen Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
1,286
+24
+2% +$24.5K 0.11% 69
2026
Q1 		$1.16M Buy
1,262
+39
+3% +$39.5K 0.09% 74
2025
Q4 		$1.31M Sell
1,223
-7
-0.6% -$6.69K 0.11% 65
2025
Q3 		$938K Sell
1,230
-14
-1% -$10.4K 0.08% 78
2025
Q2 		$970K Sell
1,244
-27
-2% -$21K 0.09% 74
2025
Q1 		$1.05M Sell
1,271
-3
-0.2% -$2.5K 0.11% 67
2024
Q4 		$984K Sell
1,274
-5
-0.4% -$4.14K 0.1% 71
2024
Q3 		$1.13M Buy
1,279
+14
+1% +$12.6K 0.11% 63
2024
Q2 		$1.15M Sell
1,265
-341
-21% -$273K 0.12% 62
2024
Q1 		$1.25M Buy
1,606
+83
+5% +$59.1K 0.13% 59
2023
Q4 		$888K Buy
1,523
+109
+8% +$63.6K 0.1% 65
2023
Q3 		$759K Sell
1,414
-44
-3% -$22.7K 0.1% 67
2023
Q2 		$684K Buy
1,458
+277
+23% +$116K 0.09% 71
2023
Q1 		$405K Buy
1,181
+42
+4% +$14.2K 0.06% 99
2022
Q4 		$417K Buy
1,139
+496
+77% +$176K 0.07% 90
2022
Q3 		$208K Sell
643
-7,426
-92% -$2.35M 0.04% 131
2022
Q2 		$691K Sell
8,069
-506
-6% -$152K 0.13% 57
2022
Q1 		$708K Sell
8,575
-366
-4% -$94.2K 0.11% 55
2021
Q4 		$547K Buy
8,941
+677
+8% +$172K 0.09% 70
2021
Q3 		$486K Buy
8,264
+180
+2% +$44.4K 0.09% 71
2021
Q2 		$510K Sell
8,084
-89
-1% -$17.9K 0.09% 75
2021
Q1 		$456K Sell
8,173
-71
-0.9% -$13.9K 0.08% 82
2020
Q4 		$340K Buy
8,244
+2,844
+53% +$425K 0.06% 93
2020
Q3 		$243K Buy
+5,400
New +$836K 0.05% 105

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Traphagen Investment Advisors's LLY Position: Q2 2026 in Review

Traphagen Investment Advisors increased its Eli Lilly (LLY) stake by 1.9% in Q2 2026, buying an estimated $24.5K and bringing the position to 1,286 shares worth $1.54M. The position accounts for 0.11% of the portfolio, ranked #69.

Traphagen Investment Advisors first reported a position in LLY in Q3 2020 and has held it in 24 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Traphagen Investment Advisors held 1,286 shares of Eli Lilly worth $1.54M as of Q2 2026.
  • Traphagen Investment Advisors bought 24 Eli Lilly shares in Q2 2026, an estimated $24.5K.
  • Eli Lilly made up 0.11% of Traphagen Investment Advisors's portfolio in Q2 2026, its #69 holding.
  • Traphagen Investment Advisors first reported a position in Eli Lilly in Q3 2020 and has held it in 24 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Traphagen Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.